Petros Pharmaceuticals, Inc.
PTPI
$0.0318
-$0.0016-4.79%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -61.24% | -75.41% | 62.79% | 67.90% | 57.92% |
| Total Depreciation and Amortization | -14.33% | -35.86% | -34.64% | -43.13% | -49.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 339.60% | 292.34% | -434.36% | -152.54% | -131.95% |
| Change in Net Operating Assets | 141.31% | 346.01% | 435.32% | -106.16% | 309.52% |
| Cash from Operations | 60.96% | 65.87% | 15.98% | -96.09% | 3.11% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 30.80% | 47.72% | 10.61% | 11.47% | -2.23% |
| Issuance of Common Stock | -41.95% | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -63.85% | -211.88% | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -73.74% | -160.67% | -159.95% | 823.81% | 1,095.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -111.73% | -346.17% | -307.35% | 101.27% | 129.52% |